Business of Medicine News Index

 
 
  • EU Agency Backs J&J's Intelence for Some HIV Patients The European Medicines Agency has recommended approval of Johnson & Johnson's Intelence for use in combination with other medicines for the treatment of HIV in adults, the drugs watchdog said on Thursday.
  • Medicare Private Plans Underestimate Profits: GAO Private health plans contracting in the federal Medicare program have underestimated profits, which could inflate government reimbursement, a congressional watchdog group said on Wednesday.
  • U.S. Medicare Bill With Big HMO Cuts Faces Senate Vote A bill with about $13 billion in cuts to private health insurers in Medicare is expected to face a vote in the U.S. Senate as early as Thursday, as backers work off momentum from an unexpected victory earlier this week.
  • U.S. Judge Dismisses Suit Over Veteran Health Care A U.S. judged dismissed on Wednesday a lawsuit against the U.S. Department of Veterans Affairs that claimed the government was failing to meet the mental health needs of former troops, who have a rate of suicide far higher than the general population.
  • Birth Control Pill Yasmin Goes Generic The drug will be available by July 1; the generic version of Yaz is expected in 2011.
  • U.S. Electronic Health-Record Standards Agreed U.S. consumer groups, insurers and privacy advocates together with Google Inc and Microsoft Corp said on Wednesday they have agreed to standards intended to speed adoption of personal electronic health records.
  • Merck's Gardasil Not Cleared for Older Women U.S. regulators have told Merck & Co they cannot yet approve Merck's application to expand marketing of its HPV vaccine Gardasil to an older group of women, the drugmaker said Wednesday.
  • Sanofi Obesity Drug Gets Final Okay From UK's NICE Sanofi-Aventis won a final green light for its obesity drug Acomplia (rimonabant) from Britain's cost-effectiveness watchdog NICE on Wednesday, clearing the way for doctors to prescribe it on the state health service.
  • UK's NICE Backs Baraclude for Hepatitis B Bristol-Myers Squibb Co said on Wednesday its antiviral drug Baraclude (entecavir) for treating hepatitis B had been recommended by Britain's cost-effectiveness watchdog NICE.
  • CME/CE World Health Organization Issues Safety Checklist for Surgical Teams To improve surgical safety and reduce surgical errors worldwide, the World Health Organization has released a new safety checklist for surgical teams to use in operating rooms.
  • Tenet to Sell Broadlane Stake, Proceeds $155 Mln Hospital operator Tenet Healthcare Corp said on Monday it will sell its interest in health care services company Broadlane Inc to TowerBrook Capital Partners L.P. for proceeds of about $155 million.
  • US Bill With Billions in Health Plan Cuts Passes House The House Tuesday overwhelmingly approved a bill that would shave billions of dollars from health plans that contract with the federal Medicare program.
  • Personalized Medicine Requires Regulatory Change Changes need to be made in the way therapies are developed, approved, and paid for if the potential of personalized medicine is to be realized, experts say.
  • Better Linkage After HIV Diagnosis Can Speed Initiation of Medical Care Improving the linkage between HIV testing sites and treatment sites can speed the initiation of medical care after a diagnosis of HIV infection is confirmed, according to a report in the June 9th issue of the Archives of Internal Medicine.
  • Drugmakers Urged to Cut Anti-Diarrhoea Vaccine Prices Health experts at a conference on infectious diseases in the Malaysian capital urged drugmakers on Friday to cut prices of anti-diarrhoea vaccines sold to poorer nations so that more children could benefit from them.
  • US FDA Seeks India Post for Food, Drug Checks The U.S. Food and Drug Administration hopes to establish operations in India by year's end to better police the growing volume of food, medicines, medical devices and animal feed exported to the United States, a top official told Reuters on Thursday.
  • Concerns Remain Over Heart Imaging Agents: U.S. FDA U.S. health regulators remain concerned about the safety of contrast agents used to enhance echocardiogram heart imaging tests, according to Food and Drug Administration documents released on Friday.
  • CME Cymbalta Approved for Fibromyalgia The FDA has approved a new indication for duloxetine HCl delayed-release capsules (Cymbalta) for treatment of fibromyalgia.
  • Aetna Backs Forecast After Coventry Warning Health insurer Aetna Inc on Thursday reaffirmed its second-quarter and full-year earnings forecasts a day after rival Coventry Health Care Inc cut its outlook.
  • Archbishop Tutu Urges US Senate to Pass AIDS Bill Archbishop Desmond Tutu of South Africa on Wednesday urged the U.S. Senate to pass a bill that would more than triple spending to fight AIDS, malaria and tuberculosis in Africa and other parts of the world.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.